A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports.
Pennsylvania prosecutors had filed suit against J&J in 2007, trying to recover expenses incurred by the state’s Medicaid program for reimbursing pharmacies over the purchase of Risperdal. Prosecutors alleged that J&J had promoted Risperdal for unapproved – or “off-label” – ...
continue reading...
According to a story in the U.K. newspaper Daily Express, a study found that people who snore are three times more likely to suffer a potentially fatal blood clot.
The Pennsylvania Record reports that attorney Michael Katz of Lopez McHugh has filed a product liability claim against GlaxoSmithKline, on behalf of a New York woman who alleges the pharmaceutical company’s anti-Lyme Disease vaccine harmed her.
An entry on the blog The Poptort.com mentions a civil complaint by the U.S. attorney’s office in Boston against drug maker Forest Laboratories, alleging the company defrauded the government out of millions of dollars by illegally marketing Celexa and Lexapro, two versions of the anti-depressant, “citalopram,” for unapproved uses in children and adolescents.
According to a Bloomberg report, Bayer has said that settlements of U.S. lawsuits over its Yasmin line of birth control pills have reached more than $402 million.
